Skip to main content

and
  1. Article

    Open Access

    Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

    Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying antirheuma...

    Alyssa Dominique, Merete Lund Hetland, Axel Finckh in Arthritis Research & Therapy (2023)

  2. No Access

    Article

    Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis

    Juvenile idiopathic arthritis (JIA) encompasses several forms of chronic inflammatory arthritis of unknown etiology presenting in children < 16 years of age, with a minimum symptom duration of 6 weeks. Approxi...

    Hermine I. Brunner, Robert Wong, Marleen Nys, Tzuyung D. Kou in Pediatric Drugs (2020)